JOHN P. BRANCACCIO

Profile

First Name

: JOHN

Middle Name

: P.

Last Name

: BRANCACCIO

Related Companies
Titles
Company Name
Related People
DIRECTOR
ALFACELL CORP
JOANNE BARSA, JOHN BRANCACCIO, STEPHEN K. CARTER, DONALD R. CONKLIN, LAWRENCE A. KENYON, FRED KNOLL, CHARLES MUNIZ, PATRICK OSTRONIC, PATRICK OSTRONICK, KUSLIMA SHOGEN, DAVID SIDRANDKY, DAVID SIDRANSKY, JAMIE SULLEY, JAMIE SULLY, PAUL WEISS, PAUL M. WEISS
DIRECTOR
TAMIR BIOTECHNOLOGY, INC.
JOANNE BARSA, JOHN BRANCACCIO, STEPHEN K. CARTER, DONALD R. CONKLIN, LAWRENCE A. KENYON, FRED KNOLL, CHARLES MUNIZ, PATRICK OSTRONIC, PATRICK OSTRONICK, KUSLIMA SHOGEN, DAVID SIDRANDKY, DAVID SIDRANSKY, JAMIE SULLEY, JAMIE SULLY, PAUL WEISS, PAUL M. WEISS
DIRECTOR
CONTRAVIR PHARMACEUTICALS, INC.
THOMAS ADAMS, SIREESH APPAJOSYULA, TIMOTHY BLOCK, JOHN BRANCACCIO, JOHN CAVAN, BERNARD F. DENOYER, ROBERT FOSTER, TODD HOBBS, BILL HORNUNG, GARY JACOB, GARY S. JACOB, GARY S. JACOBS, KAOUTHAR LBIATI, ARNOLD LIPPA, CHASE LOPRIORE, VINCENT LOPRIORE, CHRISTOPHER MCGUIGAN, MICHAEL PURCELL, ANAND REDDI, JAMES SAPIRSTEIN, GARY STETZ, PETRUS WIJNGAARD
DIRECTOR
TROVAGENE, INC.
THOMAS ADAMS, THOMAS H. ADAMS, THOMAS ADAMS, PH.D., JAMES ARMITAGE, JAMES O. ARMITAGE, PAUL BILLINGS, JOHN BRANCACCIO, GABRIELE CERRONE, ATHENA COUNTOURIOTIS, MARK ERLANDER, MARK ERLANDER, PH.D., GARY JACOB, GARY S. JACOB, GARY JACOB, PH.D., BRIGITTE LINDSAY, RODNEY MARKIN, RODNEY S. MARKIN, GARY W. PACE, GARY PACE, PH.D., DAVID ROBBINS, ANTONIUS SCHUH, STANLEY TENNANT, WILLIAM WELCH, LALE WHITE, STEVE ZANIBOBI, STEVE ZANIBONI
DIRECTOR
HEPION PHARMACEUTICALS, INC.
THOMAS ADAMS, SIREESH APPAJOSYULA, TIMOTHY BLOCK, JOHN BRANCACCIO, JOHN CAVAN, BERNARD F. DENOYER, ROBERT FOSTER, TODD HOBBS, BILL HORNUNG, GARY JACOB, GARY S. JACOB, GARY S. JACOBS, KAOUTHAR LBIATI, ARNOLD LIPPA, CHASE LOPRIORE, VINCENT LOPRIORE, CHRISTOPHER MCGUIGAN, MICHAEL PURCELL, ANAND REDDI, JAMES SAPIRSTEIN, GARY STETZ, PETRUS WIJNGAARD
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-07-24
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity, Debt 
2024-07-19 
2023-10-03
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-09-28 
2022-11-15
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-11-04 
2019-10-30
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2019-10-30 
2019-03-27
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity, Debt 
2019-03-13 
2014-02-14
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2014-02-04 
2013-10-04
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2013-10-03 
2012-12-27
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2012-12-14 
2009-11-02
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2009-10-19